NO131864B - - Google Patents
Download PDFInfo
- Publication number
- NO131864B NO131864B NO242870A NO242870A NO131864B NO 131864 B NO131864 B NO 131864B NO 242870 A NO242870 A NO 242870A NO 242870 A NO242870 A NO 242870A NO 131864 B NO131864 B NO 131864B
- Authority
- NO
- Norway
- Prior art keywords
- water
- soluble
- tablets
- active substances
- nitrofurantoin
- Prior art date
Links
- 239000008187 granular material Substances 0.000 claims description 29
- 239000013543 active substance Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000011230 binding agent Substances 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 6
- 230000003179 granulation Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000004898 kneading Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229960000564 nitrofurantoin Drugs 0.000 description 12
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 12
- 238000000576 coating method Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 239000008298 dragée Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 229920000945 Amylopectin Polymers 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000002360 explosive Substances 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000002011 intestinal secretion Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691931910 DE1931910B2 (de) | 1969-06-24 | 1969-06-24 | Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO131864B true NO131864B (enrdf_load_html_response) | 1975-05-12 |
| NO131864C NO131864C (enrdf_load_html_response) | 1975-08-20 |
Family
ID=5737829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO242870A NO131864C (enrdf_load_html_response) | 1969-06-24 | 1970-06-23 |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS50888B1 (enrdf_load_html_response) |
| AT (1) | AT299452B (enrdf_load_html_response) |
| DE (1) | DE1931910B2 (enrdf_load_html_response) |
| DK (1) | DK125230B (enrdf_load_html_response) |
| FI (1) | FI51765C (enrdf_load_html_response) |
| FR (1) | FR2053007A1 (enrdf_load_html_response) |
| LU (1) | LU61171A1 (enrdf_load_html_response) |
| NL (1) | NL167322C (enrdf_load_html_response) |
| NO (1) | NO131864C (enrdf_load_html_response) |
| SE (1) | SE380729B (enrdf_load_html_response) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2403080A1 (fr) * | 1977-09-15 | 1979-04-13 | Heyden Chem Fab | Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication |
| FR2407720A1 (fr) * | 1977-11-08 | 1979-06-01 | Lipha Lyonnaise Indle Pharmace | Preparations pharmaceutiques orales a activite therapeutique prolongee |
| US4370313A (en) * | 1981-10-26 | 1983-01-25 | Eaton Laboratories, Inc. | Nitrofurantoin dosage form |
| JPS61135913U (enrdf_load_html_response) * | 1985-02-12 | 1986-08-23 | ||
| JP2964195B2 (ja) * | 1992-04-28 | 1999-10-18 | エスエス製薬株式会社 | ピロキシカム錠及びその製造法 |
| AR017512A1 (es) | 1997-08-22 | 2001-09-12 | Smithkline Beecham Corp | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas |
| AR016827A1 (es) | 1997-08-22 | 2001-08-01 | Smithkline Beecham Corp | PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195886A (enrdf_load_html_response) * | 1954-03-25 | |||
| NL108838C (enrdf_load_html_response) * | 1956-03-27 |
-
1969
- 1969-06-24 DE DE19691931910 patent/DE1931910B2/de not_active Ceased
-
1970
- 1970-06-19 DK DK318470A patent/DK125230B/da not_active IP Right Cessation
- 1970-06-22 LU LU61171A patent/LU61171A1/xx unknown
- 1970-06-22 FI FI174370A patent/FI51765C/fi active
- 1970-06-23 NO NO242870A patent/NO131864C/no unknown
- 1970-06-23 SE SE865970A patent/SE380729B/xx unknown
- 1970-06-23 NL NL7009172A patent/NL167322C/xx not_active IP Right Cessation
- 1970-06-23 JP JP5467670A patent/JPS50888B1/ja active Pending
- 1970-06-23 AT AT565570A patent/AT299452B/de not_active IP Right Cessation
- 1970-06-24 FR FR7023299A patent/FR2053007A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2053007B1 (enrdf_load_html_response) | 1974-08-30 |
| LU61171A1 (enrdf_load_html_response) | 1970-08-26 |
| JPS50888B1 (enrdf_load_html_response) | 1975-01-13 |
| FR2053007A1 (en) | 1971-04-16 |
| SE380729B (sv) | 1975-11-17 |
| NO131864C (enrdf_load_html_response) | 1975-08-20 |
| FI51765B (enrdf_load_html_response) | 1976-12-31 |
| DK125230B (da) | 1973-01-22 |
| DE1931910B2 (de) | 1974-11-28 |
| FI51765C (fi) | 1977-04-12 |
| NL7009172A (enrdf_load_html_response) | 1970-12-29 |
| AT299452B (de) | 1972-06-26 |
| DE1931910A1 (de) | 1971-01-07 |
| NL167322C (nl) | 1981-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK175306B1 (da) | Fremgangsmåde til fremstilling af et farmaceutisk granulat | |
| EP0188040B1 (en) | Slow release solid preparation | |
| CN101836978B (zh) | 含有单一晶型的固体制剂 | |
| DK144306B (da) | Grundmasse til anvendelse ved fremstilling af en farmaceutisk enhedsdosis med langsom frigoerelse af en aktiv bestanddel samt fremgangsmaade til fremstilling deraf | |
| NO331689B1 (no) | Oral farmasoytisk sammensetning omfattende rivastigmin, samt anvendelse av rivastigmin | |
| EP0301006B1 (en) | Methylprednisolone/sodium carboxymethyl starch tablet composition | |
| CN102091051B (zh) | 一种别嘌醇双释放制剂及其制备方法 | |
| NO173081B (no) | Fremgangsmaate for fremstilling av et retard-preparat av ibuprofen | |
| JPS61148115A (ja) | 難溶性薬物の徐放性製剤及びその製造法 | |
| NO131864B (enrdf_load_html_response) | ||
| CN101647785A (zh) | 格列齐特缓释片及其制备方法 | |
| EP2560618A1 (en) | Melt-granulated fingolimod | |
| EA036288B1 (ru) | Фармацевтические лекарственные формы | |
| TWI721946B (zh) | 色瑞替尼調配物 | |
| Salunkhe et al. | Formulation and evaluation of floating pulsatile drug delivery system of Metoprolol tartrate | |
| NO331480B1 (no) | Farmasoytiske sammensetninger med kontrollert frigivelse | |
| GB2142823A (en) | Sustained release indomethacin or niomethacin formulations | |
| CN111658627A (zh) | 一种使盐酸二甲双胍快速溶出的方法 | |
| TWI745598B (zh) | 非布司他控釋組合物及其製備方法 | |
| CN108324697B (zh) | 一种含枸橼酸莫沙必利的胶囊剂及其制备方法 | |
| CN106109428B (zh) | 瑞格列奈二甲双胍的制剂工艺 | |
| RU2149001C1 (ru) | Ноотропное лекарственное средство и способ его получения | |
| DK144261B (enrdf_load_html_response) | ||
| CN103142527A (zh) | 恩替卡韦钾片及其制备方法 | |
| EA005596B1 (ru) | Твёрдая лекарственная форма, включающая циталопрам |